Skip to content

Author

Pedro Lucas Schimack Cosentino

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Reported effects of glucagon-like peptide-1 receptor agonists in multiple sclerosis: a scoping review of preclinical and clinical studies

Multiple sclerosis (MS) is a neuroinflammatory and neurodegenerative disease whose available therapies target peripheral immunity, leaving neurodegeneration unaddressed. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have shown neuroprotective and anti-inflammatory effects in preclinical models of neurodegenerat...

João Pedro Henriques, Maria J. S. Henriques, Gomes Ribeiro Rafael da Cunha et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.